LBO — UF HEALTH SHANDS
IRR: 17.1% | MOIC: 2.20x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.1%
IRR
2.20x
MOIC
$2.4B
Entry EV
$3.7B
Exit EV
$1.2B
Equity Invested
Sources & Uses
S&UTotal · $2.4B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $935.3M | 38.8% | |
| Sub Debt | $233.8M | 9.7% | |
| Equity | $1.2B | 51.5% | |
| Enterprise Value | $2.3B | 97.1% | |
| Transaction Fees | $70.1M | 2.9% | |
| Total Uses | $2.4B | 100.0% |
Interpretation
INTAt 2.20x MOIC and 17.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $352.6M |
| Exit Ev | $3.7B |
| Net Debt At Exit | $970.8M |
| Equity At Exit | $2.7B |
| Equity Invested | $1.2B |
| Total Value Created | $1.5B |
| Value From Growth | $1.2B |
| Value From Multiple | $116.9M |
| Value From Deleveraging | $198.3M |